Table 3

Lipid levels in responders upon rituximab in RA patients treated with rituximab (n=32)

Baseline1 Month3 Months6 Months
Total cholesterol, mmol/l5.21+0.24*+0.08+0.09
HDL cholesterol, mmol/l1.36+0.08*−0.01+0.07
Atherogenic index4.13−0.12−0.05−0.29
LDL cholesterol, mmol/l3.19+0.08+0.04−0.00
Triglycerides, mmol/l1.43+0.20***+0.18*+0.08
Apo A-I, g/l1.65+0.09*+0.04+0.08
Apo B, g/l0.90+0.02−0.01−0.01
Apo B to Apo A-I ratio0.57−0.03*−0.03*−0.05*
  • Values of lipids at different time points are regression coefficients (βs).

  • β Represents the estimated change at a different time point in GEE analysis.

  • * p<0.05,

  • ** p<0.10.

  • GEE, generalised estimating equation; HDL, high density lipoprotein; LDL, low density lipoprotein; RA, rheumatoid arthritis.